The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Potti et al., N Engl J Med 355(6):570-580 August 10, 2006.

Correction
PreviousPrevious
Volume 356:201-202 January 11, 2007 Number 2

A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Potti, A.
A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer . Figure 4 presents an analysis of samples from a Cancer and Leukemia Group B (CALGB) 9761 trial conducted to validate the performance of a predictive model for early-stage non–small-cell lung cancer (NSCLC). Some of the samples used for this analysis were from a study that was a lead-in to CALGB 9761, collected under a protocol that formed the basis for CALGB 9761 but before the official initiation of the trial. Review of these data also identified a systematic error in the entry of patients' ages in the database, . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.